Cholelithiasis

Adverse events on the FDA labels, with the canonical evidence anchors.

Definition

Gallstones. Listed in Section 5 of every FDA-approved GLP-1 label. Wegovy reports 1.6% vs 0.7% placebo; Saxenda reports 2.2% vs 0.8%. The He et al 2022 meta-analysis pooled the GLP-1 risk at RR 1.37 (95% CI 1.23-1.52).

GLP-1 + gallbladder/biliary disease →

Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.

Related terms in Side effects

Ileus
Telogen effluvium
Ozempic face
Medullary thyroid carcinoma (MTC)
Lean mass loss

Looking for more depth?

GLP-1 + gallbladder/biliary disease
Browse the full GLP-1 glossary (51 terms across 8 categories)
Research articles — primary-source deep dives
Tools and calculators
Compare GLP-1 telehealth providers